Singapore markets closed
Straits Times Index
3,144.76 -38.85 (-1.22%) S&P 500
5,061.82 -61.59 (-1.20%) Dow
37,735.11 -248.13 (-0.65%) Nasdaq
15,885.02 -290.08 (-1.79%) Bitcoin USD
62,712.41 -3,605.85 (-5.44%) CMC Crypto 200
885.54 0.00 (0.00%)
Emergent BioSolutions Inc. (EBS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 2.0600 |
| Open | 2.0600 |
| Bid | 1.9300 x 2900 |
| Ask | 1.9700 x 2900 |
| Day's range | 1.9500 - 2.1300 |
| 52-week range | 1.4200 - 11.6600 |
| Volume | |
| Avg. volume | 3,048,011 |
| Market cap | 103.734M |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
Net Loss Narrows in Q4; Full Year Revenues Hit Guidance Mid-Point
- Zacks
Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales
Emergent (EBS) reports mixed earnings for fourth-quarter 2023. The company signs a forbearance agreement with its lenders, effective till April 2023-end.
- Insider Monkey
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript March 6, 2024 Emergent BioSolutions Inc. misses on earnings expectations. Reported EPS is $-0.77 EPS, expectations were $-0.33. Emergent BioSolutions Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, […]
© 2024 Yahoo. All rights reserved.